Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human NG2 Antibodies:
anti-Mouse (Murine) NG2 Antibodies:
anti-Rat (Rattus) NG2 Antibodies:
Go to our pre-filtered search.
Human Monoclonal NG2 Primary Antibody for CyTOF, FACS - ABIN4900825
Higgins, Bolteus, Donovan, Hasegawa, Doey, Al Sarraj, King, Ashkan, Roncaroli, Fillmore, Pilkington: Expression of the chondroitin sulphate proteoglycan, NG2, in paediatric brain tumors. in Anticancer research 2014
Show all 7 Pubmed References
Human Monoclonal NG2 Primary Antibody for ICC, FACS - ABIN251133
Legg, Jensen, Broad, Leigh, Watt: Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis. in Development (Cambridge, England) 2003
Show all 6 Pubmed References
Human Monoclonal NG2 Primary Antibody for FACS - ABIN4898760
Yuan, Orcholski, Panaroni, Shuffle, Huang, Jiang, Tian, Vladar, Wang, Nicolls, Wu, de Jesus Perez: Activation of the Wnt/planar cell polarity pathway is required for pericyte recruitment during pulmonary angiogenesis. in The American journal of pathology 2014
Show all 5 Pubmed References
Human Monoclonal NG2 Primary Antibody for FACS, ELISA - ABIN1724837
Wang, Katayama, Wang, Yu, Favoino, Sakakura, Favole, Tsuchikawa, Silver, Watkins, Kageshita, Ferrone: Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4. in Cancer research 2011
Show all 2 Pubmed References
Human Monoclonal NG2 Primary Antibody for FACS - ABIN4898759
Guijarro-Muñoz, Cuesta, Alvarez-Cienfuegos, Geng, Alvarez-Vallina, Sanz: The axonal repellent Slit2 inhibits pericyte migration: potential implications in angiogenesis. in Experimental cell research 2012
Show all 2 Pubmed References
Human Monoclonal NG2 Primary Antibody for FACS - ABIN4898757
Frassanito, Rao, Moschetta, Ria, Di Marzo, De Luisi, Racanelli, Catacchio, Berardi, Basile, Menu, Ruggieri, Nico, Ribatti, Fumarulo, Dammacco, Vanderkerken, Vacca: Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies. in Leukemia 2014
This study revealed that CSPG4 interacted with perlecan (show HSPG2 Antibodies) to support cell adhesion and actin polymerization and the data suggest a novel mechanism by which CSPG4 expressing cells might attach to perlecan (show HSPG2 Antibodies)-rich matrices so as those found in connective tissues and basement membranes.
Both tumor cell and vascular NG2 expression were shown to be present in a significant number of patients with colorectal cancer and this makes NG2 a double target for anti-tumor therapies.
NG2 may represent a promising target for the modulation of ICAM-1 (show ICAM1 Antibodies)-mediated immune responses.
In addition to establishing the binding region for CSPG4, this work ascribes for the first time a role in TcdB CROPs in receptor binding and further clarifies the relative roles of host receptors in TcdB pathogenesis.
of NG2/CSPG4 rather than changes in CD44 (show CD44 Antibodies) or Ki-67 (show MKI67 Antibodies) expression is associated with low overall survival in glioblastoma multiforme patients
The results indicate that CSPG4/NG2 has roles in regulating chondrosarcoma cell function in relation to growth, spread and resistance to chemotherapy.
A positive CSPG4 stain may be associated with an increased risk of metastasis and mortality from chordoma.
CSPG4 is a cell surface proteoglycan (show Vcan Antibodies) regulated by interleukin 11 (show IL11 Antibodies) in human endometrial epithelial cancer cells. the data suggest that CSPG4 inhibition may impair endometrial cancer progression by reducing cancer cell proliferation, migration and potentially epithelial-to-mesenchymal transition.
These data suggest the possible involvement of GD3 and NG2 in pre/pro-tumorigenic events occurring in the complex microenvironment of the tissue surrounding glioblastoma
the ratio of serum proteoglycan 4 (show PRG4 Antibodies) to protease C1 inhibitor (show SERPING1 Antibodies) may be used for screening of early breast cancer.
This study confirm the earlier report that EAE disease severity is ameliorated in the absence of NG2 (show Vcan Antibodies) proteoglycan (show Vcan Antibodies), but do not give any indication of NG2 (show Vcan Antibodies) expression by immune cells in naive and immunized mice.
These findings suggest that NG2 (show Vcan Antibodies) expression mediates inflammatory reactions and neurodegeneration in microglial cells in response to central nervous system injury, potentially by regulating FAK (show PTK2 Antibodies) phosphorylation.
NG2 (show Vcan Antibodies) may represent a promising target for the modulation of ICAM-1 (show ICAM1 Antibodies)-mediated immune responses.
Results demonstrate that NG2 (show Vcan Antibodies) plays an important role in the induction and progression of experimental autoimmune encephalomyelitis. We further demonstrate that this role exerts itself at both the central nervous system/blood-brain barrier and immune system levels
Loss of chondroitin sulfate proteoglycan NG2 (NG2) does not affect oligodendroglial differentiation.
Study found significant differences in transcript and protein expression, electrophysiological properties and proliferative capacity of NG2 (show Vcan Antibodies) glia in the mouse forebrain, suggesting the co-existence of several subpopulations of NG2 (show Vcan Antibodies) glia.
chondroitin sulfate proteoglycan 4 (CSPG4) is a potential mesenchymal progenitor cells marker.
Results suggest that NG2 (show Vcan Antibodies) may counteract neurological deficits and adverse glial responses in traumatic brain injury
NG2 (show Vcan Antibodies) protein is not required for glutamatergic neuron-NG2 (show Vcan Antibodies) cell synaptic signaling
This study demonstrated that NG2 (show Vcan Antibodies) is an important factor in OPC-dependent regeneration of white matter following spinal cord demyelination.
A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells.
chondroitin sulfate proteoglycan 4 (melanoma-associated)
, chondroitin sulfate proteoglycan NG2
, melanoma chondroitin sulfate proteoglycan
, melanoma-associated chondroitin sulfate proteoglycan
, AN2 proteoglycan
, AN2/NG2 proteoglycan
, nerve/glial antigen 2
, proteoglycan AN2
, HSN tumor-specific antigen
, membrane-spanning proteoglycan NG2